Gene mutations in adult Japanese patients with dilated cardiomyopathy

Circulation Journal

Volumn 69, Issue 2, 2005, Pages 150-153

  Shimizu, Masami ^a   Ino, Hidekazu ^a   Yasuda, Toshihiko ^a   Fujino, Noboru ^a   Uchiyama, Katsuharu ^a   Mabuchi, Tomohito ^a   Konno, Tetsuo ^a   Kaneda, Tomoya ^a   Fujita, Takashi ^a   Masuta, Eiichi ^a   Katoh, Masahiro ^a   Funada, Akira ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Dilated cardiomyopathy; Dystrophin; Myosin binding protein C

Indexed keywords

ALPHA ACTIN; ALPHA TROPOMYOSIN; CYTOSKELETON PROTEIN; DYSTROPHIN; LAMININ; MYOSIN BINDING PROTEIN C; MYOSIN BINDING PROTEIN C3; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN; TROPOMYOSIN; TROPONIN C; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; EXON; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HEART MUSCLE CELL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SARCOMERE;

AGED; CARDIOMYOPATHY, DILATED; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; DEATH, SUDDEN; DYSTROPHIN; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY, MOLECULAR; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC SCREENING; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION; SARCOMERES;

EID: 20044388707     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.150     Document Type: Article

References (35)

1. Matsumori A, Furukawa Y, Hasegawa K, Sato Y, Nakagawa H, Morikawa Y, et al. Epidemiologic and clinical characteristics of cardiomyopathies in Japan: Results from nationwide surveys. Circ J 2002; 66: 323-336.
2. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992; 326: 77-82.
3. Honda Y, Yokota Y, Yokoyama M. Familial aggregation of dilated cardiomyopathy: Evaluation of clinical characteristics and prognosis. Jpn Circ J 1995; 59: 589-598.
4. Grunig E, Tasman JA, Kucherer H, Franz W, Kubler W, Katus HA. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998; 31: 186-194.
5. Ross J Jr. Dilated cardiomyopathy: Concepts derived from gene deficient and transgenic animal models. Circ J 2002; 66: 219-224.
6. Bowles NE. The molecular biology of dilated cardiomyopathy. Eur Heart J Suppl 2002; 4(Suppl 1): 12-17.
7. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000; 343: 1688-1696.
8. Murphy RT, Mogensen J, Shaw A, Kubo T, Hughes S, McKenna WJ. Novel mutation in cardiac troponin 1 in recessive idiopathic dilated cardiomyopathy. Lancet 2004; 363: 371-372.
9. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998; 280: 750-752.
10. Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001; 33: 723-732.
11. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitas K, Sasse-Klaassen S, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002; 30: 201-204.
12. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, et al. X-linked dilated cardiomyopathy: Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993; 87: 1854-1865.
13. Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000; 106: 655-662.
14. Barresi R, Di Blasi C, Negri T, Brugnoni R, Vitali A, Felisari G, et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet 2000; 37: 102-107.
15. Li D, Tapscoft T, Gonzalez O, Burch PE, Quinones MA, Zoghbi WA, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999; 100: 461-464.
16. Olson TM, Illenberger S, Kishimoto NY, Huttelmaier S, Keating MT, Jockusch BM. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 2002; 105: 431-437.
17. Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999; 341: 1715-1724.
18. Maron BJ, McKenna WJ, Danielson GK, Shah PM, Kappenberger LJ, Spencer WH III, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A Report of the American College Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42: 1687-1713.
19. Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, et al. Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J 1999; 20: 93-102.
20. Chamberlain JS, Gibbs RA, Ranier JE, Casky CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: A guide to methods and applications. New York: Academic Press; 1990; 272-281.
21. Beggs AH, Kunkel LM. Improved diagnosis of Duchenne/Becker muscular dystrophy. J Clin Invest 1990; 85: 613-619.
22. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
23. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, et al. Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107: 2227-2232.
24. Konno T, Shimizu M, Ino H, Matsuyama T, Yamaguchi M, Terai H, et al. A novel missense mutation in the myosin binding protein-C is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilatation in elderly patients. J Am Coll Cardiol 2003; 41: 781-786.
25. Ogimoto A, Hamada M, Nakura J, Shigematsu Y, Hara Y, Ohtsuka T, et al. 17-year follow-up study of a patient with obstructive hypertrophic cardiomyopathy with a deletion mutation in the cardiac myosin binding protein C gene. Circ J 2004; 68: 174-177.
26. Noji Y, Shimizu M, Ino H, Higashikata T, Yamaguchi M, Nohara A, et al. Increased matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction. Circ J 2004; 68: 355-360.
27. Muntoni F, Cau M, Ganau A, Cougiu R, Arvedi G, Mateddu A, et al. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993; 329: 921-925.
28. Michels VV, Pastores GM, Moll PP, Driscoll DJ, Miller FA, Burnett JC, et al. Dystrophin analysis in idiopathic dilated cardiomyopathy. J Med Genet 1993; 30: 955-957.
29. Arbustini E, Marta D, Morbini P, Bello BD, Banchieri N, Pilotto A, et al. Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 2000; 35: 1760-1768.
30. Shiga N, Matsuo M, Yokoyama M, Yokota Y. Study on mutations affecting the muscle promoter/first exon of the dystrophin gene in 92 Japanese dilated cardiomyopathy patients. Am J Med Genet 1998; 23: 226-227.
31. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, et al. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion. Am J Hum Genet 1989; 45: 498-506.
32. Cohen N, Muntoni F. Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 2004; 90: 835-841.
33. Muntoni F, Di Lenarda A, Porcu M, Sinagra G, Mateddu A, Marrosu G, et al. Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart 1997; 78: 608-612.
34. Melacini P, Fanin M, Danieli GA, Fasoli G, Villanova C, Angelini C, et al. Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol 1993; 22: 1927-1934.
35. Feng J, Yan J, Buzin CH, Towbin JA, Sommer SS. Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. Mol Genet Metab 2002; 77: 119-126.